{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:43:08Z","timestamp":1778805788481,"version":"3.51.4"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T00:00:00Z","timestamp":1640304000000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570835"],"award-info":[{"award-number":["81570835"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Municipal of Health Reform and Development Project","award":["2019-4"],"award-info":[{"award-number":["2019-4"]}]},{"name":"Medizinische Fakult\u00e4t Mannheim der Universit\u00e4t Heidelberg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Myopic axial elongation may be due to an equatorial enlargement of Bruch\u2019s membrane (BM), leading to a prolate eye shape and increasing strain with BM and the retinal pigment epithelium (RPE) layer at the posterior pole. The increased BM strain may cause an enlargement of Bruch\u2019s membrane opening (BMO) of the optic nerve head, with the subsequent development and enlargement of parapapillary gamma zone as BM-free parapapillary zone. The increased strain within BM and RPE may also cause lacquer cracks (LCs) as linear breaks in the RPE and \/ or BM. Studies suggested that a more marked gamma zone enlargement is associated with lower prevalence of LCs or macular BM defects. Here report on the disappearance of a LC during a 10-year follow-up of a highly myopic eye, concurrent with a marked increase in gamma zone.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 56-year-old woman showed in her right eye (axial length measured 30.69\u2009mm) a LC, vertically oval optic disc, and parapapillary gamma zone in 2001. When re-examined in 2006, gamma zone had enlarged, while the LC was no longer detectable. In 2011, the LC was not visible neither upon ophthalmoscopy and or upon optical coherence tomography (OCT), while gamma zone had further enlarged. The gamma zone enlargement occurred in a direction perpendicular to the direction of the former LC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The observation suggest that a LC can decrease in width, in temporal association with an enlargement of gamma zone. It fits with the notion that an enlargement of the BMO (i.e., enlarging gamma zone) may lead to a relaxation of the BM strain and subsequently to a decrease in the width of the LC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-021-02216-7","type":"journal-article","created":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T13:02:36Z","timestamp":1640350956000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Decreasing myopic lacquer crack and widening parapapillary gamma zone: case report"],"prefix":"10.1186","volume":"21","author":[{"given":"Rahul A.","family":"Jonas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan Chuan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2972-5227","authenticated-orcid":false,"given":"Jost B.","family":"Jonas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya Xing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,24]]},"reference":[{"key":"2216_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00006982-199616010-00006","volume":"16","author":"K Ohno-Matsui","year":"1996","unstructured":"Ohno-Matsui K, Tokoro T. The progression of lacquer cracks in pathologic myopia. Retina. 1996;16:29\u201337.","journal-title":"Retina."},{"key":"2216_CR2","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/S0002-9394(14)76618-8","volume":"106","author":"RM Klein","year":"1988","unstructured":"Klein RM, Green S. The development of lacquer cracks in pathologic myopia. Am J Ophthalmol. 1988;106:282\u20135.","journal-title":"Am J Ophthalmol"},{"key":"2216_CR3","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1097\/IAE.0000000000001464","volume":"37","author":"JB Jonas","year":"2017","unstructured":"Jonas JB, Ohno-Matsui K, Jiang WJ, Panda-Jonas S. Bruch membrane and the mechanism of myopization. A new theory. Retina. 2017;37:1428\u201340.","journal-title":"Retina"},{"key":"2216_CR4","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1167\/iovs.19-27331","volume":"60","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Xu L, Wei WB, Wang YX, Jonas JB. Size and shape of Bruch\u2019s membrane opening in relationship to axial length, gamma zone and macular Bruch\u2019s membrane defects. Invest Ophthalmol Vis Sci. 2019;60:2591\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2216_CR5","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1111\/aos.13537","volume":"96","author":"JB Jonas","year":"2018","unstructured":"Jonas JB, Jonas RA, Ohno-Matsui K, Holbach L, Panda-Jonas S. Corrugated Bruch's membrane in high myopia. Acta Ophthalmol. 2018;96:e147\u2013e51.","journal-title":"Acta Ophthalmol"},{"key":"2216_CR6","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.1167\/iovs.18-24775","volume":"59","author":"KM Lee","year":"2018","unstructured":"Lee KM, Choung HK, Kim M, Oh S, Kim SH. Change of beta-zone parapapillary atrophy during axial elongation: Boramae myopia cohort study report 3. Invest Ophthalmol Vis Sci. 2018;59:4020\u201330.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2216_CR7","doi-asserted-by":"publisher","first-page":"6334","DOI":"10.1167\/iovs.17-22687","volume":"58","author":"SJ Kim","year":"2017","unstructured":"Kim SJ, Campbell JP, Ostmo S, Jonas KE, Chan RVP, Chiang MF. Changes in relative position of choroidal versus retinal vessels in preterm infants. Invest Ophthalmol Vis Sci. 2017;58:6334\u201341.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2216_CR8","doi-asserted-by":"publisher","first-page":"14658","DOI":"10.1038\/s41598-021-94226-0","volume":"11","author":"JB Jonas","year":"2021","unstructured":"Jonas JB, Yan YN, Zhang Q, Jonas RA, Wang YX. Choroidal shift in myopic eyes in the 10-year follow-up Beijing eye study. Sci Rep. 2021;11:14658.","journal-title":"Sci Rep"},{"key":"2216_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1755-3768.2012.02570.x","volume":"92","author":"S Panda-Jonas","year":"2014","unstructured":"Panda-Jonas S, Xu L, Yang H, Wang YX, Jonas SB, Jonas JB. Optic disc morphology in young patients after antiglaucomatous filtering surgery. Acta Ophthalmol. 2014;92:59\u201364.","journal-title":"Acta Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-02216-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-021-02216-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-02216-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T13:02:47Z","timestamp":1640350967000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-021-02216-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2216"],"URL":"https:\/\/doi.org\/10.1186\/s12886-021-02216-7","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"27 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Medical Ethics Committee of Beijing Tongren Hospital approved the study protocol according to the declaration of Helsinki and all study participants gave their written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All study participants gave their written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Jost B. Jonas and Rahul A. Jonas: European patent application 16 720 043.5 and US patent application US 2019 0085065 A1: \u201eAgents for use in the therapeutic or prophylactic treatment of myopia or hyperopia). Patent application: Agents for the use in the therapeutic or prophylactic treatment of retinal pigment epithelium associated diseases.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"443"}}